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Abstract Familial adenomatous polyposis (FAP) is an auto-
somal dominant disorder characterized by the development of
hundreds to thousands of colonic adenomas and an increased
risk of colorectal cancer. Adenomatous polyposis coli (APC),
encoding a large multidomain protein involved in antagoniz-
ing theWnt signaling pathway, has been identified as the main
causative gene responsible for FAP. In this study, we identified
three novel mutations as well as two recurrent mutations in the
APC in five Chinese FAP families by sequencing.
Immunohistochemical analysis revealed that among these mu-
tations, a nonsense mutation (c.2510C>G) and two small de-
letions (c.2016_2047del, c.3180_3184del) led to the trunca-
tion of the APC protein and the cytoplasmic and nuclear ac-
cumulation of β-catenin in the colorectal samples from affect-
ed individuals, respectively. Our study expands the database
on mutations of APC and provides evidence to understand the
function of APC in FAP.
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Introduction
Familial adenomatous polyposis (FAP; OMIM#175100) is an
autosomal dominant disorder characterized by hundreds to
thousands of adenomatous polyposis throughout the colon
and rectum that ultimately evolve into fatal aggressive tumors
when left untreated [1]. The penetrance is approximately
100 %, with the appearance of polyps by adolescence or the
third decade of life. The incidence of FAP in the population is
approximately 1 in 8000. FAP has a relatively equal world-
wide distribution and occurs almost equally among males and
females. In addition, patients with FAPmay have extracolonic
manifestation, such as congenital hypertrophy of the retinal
pigment epithelium, dental abnormalities, and upper gastroin-
testinal polyps [2, 3]. In 1991, the adenomatous polyposis coli
(APC) gene was identified as responsible for FAP [4].
APC contains 15 exons, is located on chromosome 5q21-
q22, and encodes a large multidomain protein composed of
2843 amino acid residues, with a calculated molecular mass of
311.6 kDa [5]. It is ubiquitously expressed in various tissues,
especially throughout the large intestine and central nervous
system. As a complex functional protein, APC protein combines
with glycogen synthesis kinase 3β (GSK-3β) and axin forming
a complex called Bdestruction complex^, which prevents the
accumulation of β-catenin by mediating its phosphorylation
and degradation in the cytoplasm [6]. Therefore, the APC inac-
tivation leads to the stimulation of the Wnt signaling pathway
through decreased degradation of β-catenin. This enables β-
catenin to translocate into the nucleus, where it actives transcrip-
tion factor TCF/LEF to increase the expression of several onco-
genes, such as c-myc, cyclin D1, andMMP9 [7]. Hence, APC is
regarded as a tumor suppressor gene whose inactivation is re-
ported to result in several types of cancer, such as colon and
rectum cancer, mammary cancer, and thyroid cancer.
Moreover, APC regulates cell migration and adhesion by
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binding with cytoskeletal proteins including F-actin and micro-
tubules [2]. Furthermore, APC participates in transcriptional ac-
tivation, apoptosis, DNA repair, and meiosis [2, 8–11].
In this study, we sequenced APC in five families with FAP
from Chinese Han population and found three novel and two
recurrent mutations. Among them, two were nonsense muta-
tions, two were small deletions, and one was a missense mu-
tation. Furthermore, we collected tissue samples from three
probands among the affected families and detected the expres-
sions of the truncated APC protein as well as the consequent




Five probands from five unrelated Chinese families were di-
agnosed with FAP (Fig. 1). All affected individuals had typi-
cal manifestations and family histories as well as presence of
numerous polyps under colonoscopy examination. Diagnostic
criteria were applied as described previously [12]. The study
was approved by the Ethics Committees of China Medical
University, and all study subjects gave informed consent.
Extraction of genomic DNA and PCR
Genomic DNA samples were extracted from peripheral blood
samples as described previously [13]. Primers flanking all 15
coding exons and intron-exon boundaries of the APC gene
were designed. All fragments were amplified as follows:
1 min at 94 °C, 35 cycles (30 s at 94 °C, 30 s at 52–58 °C,
1 min at 72 °C) and 5 min at 72 °C. After amplification, the
products were purified on agarose gels and subjected to se-
quencing [13].
Immunohistochemistry
Colorectal tissues were obtained from three probands and
were paraffin-embedded. Immunohistochemistry was per-
formed in order to determine the expression of APC and β-
catenin in the samples. The sections were immunostained
using the biotin–avidin–horseradish peroxidase method as de-
scribed previously and with APC antibody against the C-
terminal epitope corresponding to amino acids 2813 to 2823
[14, 15]. Images were visualized and recorded using a Nikon
80i microscope at the indicated magnifications. As controls,




Among the five Chinese families with FAP, we found five
mutations in APC (Table 1). Three of these mutations were
novel and two were recurrent. The spectrum of mutations
Fig. 1 Pedigrees of the five families with FAP. Affected family members are represented by black symbols. The probands are indicated with arrows
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included three substitutions and two small deletions, all of
which were heterozygous (Fig. 2a–e).
In family 1, one 32-bp deletion was detected in exon 15 of
APC and was defined as c.2016_2047del (Fig. 2a). This mu-
tation was predicted to shift the reading frame from codon 673
and expected to produce a premature termination codon (PTC)
at codon 682. In family 2, a nonsensemutation was detected in
exon 14 of APC and was defined as c.1766 T>A (Fig. 2b).
This mutationwas predicted to lead to a PTC at codon 589 and
to result in truncated APC protein lacking 2254 amino acid
residues (Fig. 2b). Moreover, a deletion of the sequence
AAAAC was found between c.3180 and c.3184 in family 3,
and this 5-bp small deletion was predicted to produce a PTC at
codon 1062 (Fig. 2c).
Searching the Human Gene Mutation Database and Colon
Cancer Gene Variant Database, we did not find any previous
reports about these three variants. Upon restriction endonucle-
ase analysis, all the mutations were segregated in affected
individuals from 100 healthy and unrelated normal Chinese
subjects, suggesting that neither of themwas a polymorphism.
In addition, two recurrent mutations were detected. In fam-
ily 4, a nonsense mutation, c.2510C>G, was found which was
suspected to produce a PTC at codon 837 (Fig. 2d). Moreover,
a missense mutation in family 5 replaced a lysine with aspar-
agine at codon 516, which was shown to be a highly con-
served residue within the functional domain of the APC
(Fig. 2e).
Molecular analysis of expression patterns
Immunohistochemistry was performed to analyze the effects
of the truncations of APC in paraffin-embedded tissues from
families 1, 3, and 4, respectively. As shown in Fig. 3, the
expression of APC was positive in control samples but not
in the three affected individuals, both in adenoma and adeno-
carcinoma tissues, supporting the prediction that the truncated
APC protein in the affected individuals lacks the C-terminus.
In addition, the expression pattern of β-catenin was also
investigated in the samples described above. Higher immuno-
reactivity of β-catenin was detected in adenocarcinoma sam-
ples compared with adenoma in the three paired samples as
well as in control tissues. Moreover, β-catenin was mainly
localized at the cellular membrane in control tissues while it
was mainly localized in the cytoplasm in adenoma samples.
Additionally, in adenocarcinoma, a high level of nuclear β-
catenin was detected. Notably, the intensity ofβ-catenin stain-
ing was generally consistent with the development from ade-
nomatous polyps to colorectal cancer in each individual.
Discussion
As a large protein with multiple domains, the human APC
contains an oligomerization domain, an armadillo region,
three 15-amino acid repeats, seven 20-amino acid repeats, a
basic domain, an EB1-binding domain, and a human disc
large binding site, which is comprised by amino acids 6-57,
453-767, 1020-1070, 1265-2035, 2200-2400, 2559-2771, and
2771-2843, respectively [2, 16]. The oligomerization domain
is responsible for the formation of homodimers, which has
been demonstrated to be essential for the activity of the APC
protein. It has been suggested that the mutant protein could
disturb the activity of wild-type APC by forming heterodimers
with it [2]. The armadillo region, as a tightly conserved do-
main, is linked to protein-protein interactions. Binding part-
ners include APC-stimulated guanine nucleotide exchange
factor (Asef1), kinestin-associated protein 3 (SMAP), and
APC membrane recruitment protein 1 (AMER1), which sug-
gest that the armadillo domain might be involved in cell-cell
adhesion, cell polarization, and migration through cytoskele-
ton [2]. The armadillo domain is also responsible for the bind-
ing of APC with protein phosphatase 2A (PP2A), which re-
presses the Wnt signaling as an antagonist to GSK-3β stabi-
lization [17]. Additionally, APC displays binding sites for β-
catenin and axin/conduction at the 15- and 20-amino acid
Table 1 Mutations in the APC gene detected in this study
Patient 1 2 3 4 5
Sex Male Male Female Male Female
Age 34 42 45 55 48
Cancer location Rectal cancer Colon cancer Colorectal cancer Colorectal cancer Colorectal cancer
Polyp number Numerous Numerous Numerous Numerous Numerous
Nucleotide changes c.2016_2047del c.1766T>A c.3180_3184del c.2510C>G c.1548G>C
Amino acid changes p.Ser673Leufs*10 p.Leu589* p.Gln1062* p.Ser837* p.Lys516Asn
Exon 15 14 15 15 11
Mutation effect Small deletion Nonsense Small deletion Nonsense Missense
Novel or recurrent Novel Novel Novel Recurrent Recurrent
Truncated protein Yes Yes Yes Yes No
Tumor Biol. (2016) 37:11421–11427 11423
repeats, which are the major domains by which APC regulates
the Wnt signaling pathway. In addition, APC can bind to
microtubules via the basic domain and EB1-binding domain,
which regulate cell migration and cytoskeletal reorganization.
Furthermore, the human disc large binding site of APC at the
C-terminus might play a negative role in the cell cycle pro-
gression from the G0/G1 to S phase [2].
Most FAP cases are caused by germline mutations in APC.
Until now, more than 1500 mutations scattered through the 9-
kb coding region of the APC gene have been reported.
Mutations are located primarily at the 5′ end, but extend
throughout the length of the APC gene. Most of these are point
mutations or small deletions/insertions, and most result in N-
terminal protein fragments that cannot bind and degrade β-
catenin and thus cannot repress Wnt/β-catenin signaling path-
way [6–11, 18]. Generally, most mutations are located in exon
15 since it is the largest known exon (6557 bp long). Among
the five mutations detected in this study, three mutations were
found in this exon. Moreover, loss of heterozygosity and pro-
moter hypermethylation of APC has been observed in FAP
and colorectal cancer [2, 19–22].
In our study, four mutations, including two small deletions
and two nonsense mutations, are expected to result in a trun-
cated APC protein lacking several domains such asβ-catenin-
Fig. 2 Themutations identified in this study. Direct DNA sequencing showed a nonsensemutation in family 1 (a), a missense mutation in family 2 (b), a
small insertion in family 3 (c), a small deletion in family 4 (d), and a missense mutation in family 5 (e) in the APC gene, respectively
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binding domains and microtubule-binding domains, which
disables the ability of APC to bind toβ-catenin and could lead
to the underlying the pathogenesis of APC in families 1 to 4.
Among these mutations, three were validated as resulting in
the loss of the full-length functional APC protein and the
accumulation of cytoplasmic and nuclear β-catenin by immu-
nohistochemical staining. However, one mutation could not
be validated because samples were not available for analysis.
Fig. 3 Immunohistochemistry
evaluation of the expression of
APC and β-catenin in samples
from patients 1, 3, and 4 with
immunohistochemistry,
respectively. Photographs
(magnification ×400) of APC
(left) and β-catenin (right) are
shown
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For family 5, the transition of G to C at nucleotide 1548
changes codon 516 from the basic amino acid lysine (AAG)
to the neutral amino acid asparagine (AAC) in the highly
conserved region of armadillo domain. It is possible that this
substitution in a domain involved in protein-protein interac-
tions may change the structural formation of the APC protein,
leading to the dominant negative function of the mutant APC,
which underlies the pathogenesis of FAP in family 5.
Moreover, a large-scale study has clearly addressed the clini-
cal significance of the nuclear translocation of β-catenin with
respect to tumor progression, survival, and differential diag-
nosis [23]. Our results also indicate that nuclear accumulation
of β-catenin is correlated with stages of cancer progression in
a single individual, which suggests that β-catenin might serve
as an additional parameter for disease progression of FAP
patients [23].
Furthermore, there appears to be a genotype–phenotype
correlation between APC and FAP. For example, mutations
between codons 463 to 1444 are generally associated with
congenital hypertrophy of the retinal pigment epithelium.
Mutations between codons 1445 and 1578 are associated with
desmoid tumors, whereas mutations between codons 279 and
1309 correlated with the development of duodenal polyposis
[2, 24, 25]. Patients with APC mutations between codons
1249 and 1549 develop polyposis at an early age and exhibit
worse survival prognosis while patients with APC mutations
in codons 312 to 412 have a later onset of polyposis and
exhibit improved survival rates [22]. However, the association
between genotype and phenotype and the underlying mecha-
nisms still remain largely unknown. All patients in our study
showed no abnormalities other than colorectal adenoma and
adenocarcinoma.
Currently, about 35 % of causal mutations in FAP patients
could not be identified by Sanger sequencing in APC and
other polyposis-related genes such as MUTYH, POLD1, and
POLE. Similarly, mutations in these patients cannot be detect-
ed by fluorescent in situ hybridization (FISH), which is used
to detect large chromosomal arrangements in APC, suggesting
that the known mechanisms leading to FAP are limited
[25–28]. Recently, several groups facilitated next-generation
sequencing to identify comprehensive causative variants of
APC such as exon inversion and somatic mosaicism
[26–28]. As a powerful high-throughput tool, next-
generation sequencing might replace existing screening strat-
egies for polyposis in the future because of its convenience
and dramatically decreasing cost [1, 25, 26].
In conclusion, in this study, we identified three novel and
two recurrent mutations in the APC gene in five Chinese fam-
ilies with FAP and investigated the molecular alterations in
tissues from three affected individuals by immunohistochem-
istry. Together with previous related studies, these results give
insight into the still unclearly mechanisms leading to FAP.
Additionally, our results can be added to the APC mutation
spectrum and will contribute further to the understanding of
the FAP genotype–phenotype correlations as well as to the
pathogenesis of this disease.
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